Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO

Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. Following the end of the rev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Aging
Main Authors: Pavelka, Karel, Bruyère, Olivier, Cooper, Cyrus, Kanis, John A., Leeb, Burkhard F., Maheu, Emmanuel, Martel-Pelletier, Johanne, Monfort, Jordi, Pelletier, Jean-Pierre, Rizzoli, René, Reginster, Jean-Yves
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Current Opinion
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4756045/
https://ncbi.nlm.nih.gov/pubmed/26849131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-016-0347-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados